Routine

Burning mouth syndrome

Chronic oral burning, normal mucosa · Dental & Oral
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

A chronic burning or scalding sensation of the oral mucosa (typically tongue tip and lips) with clinically normal mucosa and no identifiable local or systemic cause (primary BMS, a neuropathic condition). Secondary causes (deficiency, candidiasis, diabetes, xerostomia, medications) must be excluded first.

Red flags

  • Visible mucosal lesion/ulceration (not BMS — investigate)
  • Associated weight loss/systemic symptoms
  • Progressive neurological symptoms
  • Non-healing lesion suggesting malignancy

Assessment

Differential diagnosis

  • Nutritional deficiency (iron, B12, folate, zinc)
  • Oral candidiasis
  • Xerostomia (Sjogren, drugs)
  • Diabetes mellitus
  • Geographic tongue / oral lichen planus
  • Medication effect (ACE inhibitors) / contact allergy

Investigations

  • History — burning without visible lesion, often bilateral and worsening through the day
  • Oral exam to confirm normal mucosa and exclude candidiasis/lichen planus
  • Bloods: FBC, ferritin, B12, folate, glucose/HbA1c, zinc
  • Salivary flow assessment / Sjogren screen if dry mouth
  • Medication review (ACE inhibitors, others)
  • Swab for Candida if suspected

Management

  • Exclude secondary causes with history, examination and blood tests
  • Correct any identified deficiency, treat candidiasis or xerostomia
  • Review and adjust contributory medications where possible
  • Explain the diagnosis of primary BMS and its benign, chronic nature (reassurance is therapeutic)
  • Advise avoiding irritants (alcohol-containing mouthwashes, spicy/acidic foods, smoking)
  • Trial topical or systemic neuropathic agents for primary BMS
  • Consider cognitive behavioural therapy / psychological support
  • Refer to oral medicine for persistent or diagnostic uncertainty

Drugs & doses

Clonazepam — 0.5 mg sucked/dissolved locally then spat, up to TDS — topical neuropathic effect (specialist)
Nortriptyline/amitriptyline — 10 mg PO nocte, titrated — neuropathic pain (specialist/GP)
Alpha-lipoic acid — 600 mg PO daily — some evidence as adjunct
Artificial saliva / pilocarpine — for associated xerostomia

Disposition

Exclude and treat secondary causes; discharge with reassurance and neuropathic/topical therapy; refer to oral medicine for persistent primary BMS and psychological support as needed.

Complications & pitfalls

  • Chronic pain and impaired quality of life
  • Anxiety/depression
  • Dietary restriction/weight loss
  • Missed secondary cause if not screened

Exam pearls

  • Diagnosis of primary BMS requires normal mucosa and exclusion of secondary causes
  • A clear explanation and reassurance that it is not cancer is itself therapeutic
  • Avoid repeated unnecessary investigations once secondary causes are excluded

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.